Cardiovascular Systems Price Target Increased to $30.00 by Analysts at Wunderlich (CSII)
Equities researchers at Wunderlich upped their price objective on shares of Cardiovascular Systems (NASDAQ:CSII) from $24.00 to $30.00 in a research report issued on Tuesday, AR Network reports. The firm currently has a “buy” rating on the stock. Wunderlich’s price target indicates a potential upside of 3.31% from the stock’s previous close.
In other Cardiovascular Systems news, VP Robert J. Thatcher sold 23,426 shares of the company’s stock in a transaction that occurred on Wednesday, October 23rd. The shares were sold at an average price of $28.19, for a total transaction of $660,378.94. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
A number of other analysts have also recently weighed in on CSII. Analysts at Benchmark Co. initiated coverage on shares of Cardiovascular Systems in a research note to investors on Tuesday, September 10th. They set a “speculative buy” rating and a $26.00 price target on the stock. Analysts at Feltl & Co. upgraded shares of Cardiovascular Systems from a “buy” rating to a “strong-buy” rating in a research note to investors on Thursday, August 8th. They now have a $27.50 price target on the stock, up previously from $19.50. Three research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $34.70.
Shares of Cardiovascular Systems (NASDAQ:CSII) traded up 0.55% on Tuesday, hitting $29.04. 278,144 shares of the company’s stock traded hands. Cardiovascular Systems has a 1-year low of $10.12 and a 1-year high of $22.84. The stock has a 50-day moving average of $20.71 and a 200-day moving average of $19.78. The company’s market cap is $723.2 million.
Cardiovascular Systems (NASDAQ:CSII) last released its earnings data on Wednesday, August 7th. The company reported ($0.28) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.30) by $0.02. The company had revenue of $28.80 million for the quarter, compared to the consensus estimate of $27.18 million. On average, analysts predict that Cardiovascular Systems will post $-1.23 earnings per share for the current fiscal year.
Cardiovascular Systems, Inc (NASDAQ:CSII) is a medical device company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.